Bionik Laboratories Corp. Stock
Stocks
BNKL
US09074A2087
Advanced Medical Equipment & Technology
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.000100 USD | +9,900.00% |
|
-.--% | +9,900.00% |
| 23-06-27 | Bionik Laboratories Corp. Announces Executive Changes | CI |
| 23-06-21 | Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023 | CI |
| Market Cap | 12 10.46 9.69 9.07 17.01 1.13K 17.12 114.96 44.55 557.33 45.04 44.08 1.94K | P/E 2022 |
-0.21x | P/E 2023 | -0.56x |
|---|---|---|---|---|---|
| Enterprise Value | 1.98M 1.73M 1.6M 1.5M 2.81M 187M 2.83M 19.02M 7.37M 92.19M 7.45M 7.29M 320M | EV / Sales 2022 |
0.17x | EV / Sales 2023 | 2.65x |
| Free-Float |
100% | Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +9,900.00% |
| 1 month | 0 | 0 | |
| Current year | 0 | 0 | |
| 1 year | 0 | 0 | |
| 3 years | 0 | 0.64 | |
| 5 years | 0 | 2.9 | |
| 10 years | 0 | 222.02 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Russo
CEO | Chief Executive Officer | 46 | 2021-07-13 |
| Director | Title | Age | Since |
|---|---|---|---|
Michal Prywata
BRD | Director/Board Member | 35 | 2019-03-17 |
| Director/Board Member | 70 | 2017-08-31 | |
Richard Russo
BRD | Director/Board Member | 46 | 2022-10-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-06-12 | Conversion | Chairman | 186,112 | 1.4416% | ||
| 23-06-12 | Conversion | Director | 3,102,878 | 24.0337% | ||
| 23-06-08 | Buy | Director | 180,555 | 1.3985% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +9,900.00% | -.--% | -.--% | -99.98% | 1.26K | ||
| +0.63% | -1.01% | +16.77% | -11.91% | 173B | ||
| +1.14% | -1.04% | -20.14% | +24.08% | 144B | ||
| -0.33% | -1.63% | -9.79% | -25.12% | 125B | ||
| +0.76% | -3.45% | -55.29% | -16.19% | 67.32B | ||
| +0.78% | +2.64% | +18.33% | -4.95% | 50.3B | ||
| -0.58% | -1.16% | -25.96% | -32.99% | 43.8B | ||
| +2.20% | -2.14% | +9.95% | +7.53% | 35.89B | ||
| -0.44% | -0.03% | +3.74% | +35.01% | 34.9B | ||
| +0.72% | -5.51% | -13.59% | -21.94% | 28.02B | ||
| Average | +990.49% | -1.67% | -7.60% | -14.65% | 70.23B | |
| Weighted average by Cap. | +0.54% | -1.89% | -7.21% | -5.19% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 1.27M 1.11M 1.03M 963K 1.81M 120M 1.82M 12.2M 4.73M 59.16M 4.78M 4.68M 205M | 1.81M 1.57M 1.46M 1.36M 2.56M 170M 2.57M 17.29M 6.7M 83.84M 6.78M 6.63M 291M |
| Net income | -10.41M -9.07M -8.4M -7.87M -14.76M -982M -14.84M -99.71M -38.64M -483M -39.07M -38.23M -1.68B | -4.95M -4.31M -3.99M -3.74M -7.01M -467M -7.05M -47.38M -18.36M -230M -18.57M -18.17M -798M |
| Net Debt | -1.99M -1.74M -1.61M -1.51M -2.82M -188M -2.84M -19.08M -7.39M -92.49M -7.48M -7.31M -321M | 1.98M 1.73M 1.6M 1.5M 2.81M 187M 2.83M 19.02M 7.37M 92.19M 7.45M 7.29M 320M |
Employees
12
- Stock Market
- Stocks
- BNKL Stock
Select your edition
All financial news and data tailored to specific country editions
















